| DCT | direct Coombs' test; discrete cosine transform; distal convoluted tubule; diurnal cortisol test; dyn... |
|---|---|
| DDC | dangerous drug cabinet; dideoxycytidine; diethyl-dithiocarbamate; direct display console; diverticul... |
| DEFT | direct epifluorescent filter technique |
| DEUV | direct electronic urethrocystometry |
| DFA | direct fluorescent antibody; discriminant function analysis; dorsiflexion assistance |
| IGFBPs | Insulin-like growth factors and their binding proteins |
|---|---|
| IGF-II | Insulin-like growth factors I and II |
| MIDCAB | Minimally Invasive Direct Coronary Artery Bypass grafting |
| MIDCAB | Minimally Invasive Direct Coronary Artery Bypass |
| MID-CABG | Minimally invasive direct coronary artery bypass grafting |
| socioeconomic factors | Social and economic factors that characterise the individual or group within the social structure. (12 Dec 1998) |
|---|---|
| steam conversion factors | (approximations) 1 pound of steam = 1,000 Btu = .3 kW. 10,000 lbs/hr steam = 300 boiler horsepower. (05 Dec 1998) |
| stem cell growth factors | <growth factor> Compounds, usually proteins, that make stem cells grow faster. (26 Mar 1998) |
| nerve growth factors | Factors which enhance the growth potentialities of sensory and sympathetic nerve cells. (12 Dec 1998) |
| debranching factors | Enzyme's that bring about destruction of branches in glycogen; formerly considered to be one enzyme, now known to be a mixture of transferases (4-alpha-d-glucanotransferase) and hydrolases (amylo-1,6-glucosidase). Synonym: debranching factors. (05 Mar 2000) |
| suppressor factors, immunologic | Proteins, protein complexes, or glycoproteins secreted by suppressor T-cells that inhibit either subsequent T-cells, B-cells, or other immunologic phenomena. Some of these factors have both histocompatibility (I-j) and antigen-specific domains which may be linked by disulfide bridges. They can be elicited by haptens or other antigens and may be mass-produced by hybridomas or monoclones in the laboratory. (12 Dec 1998) |
| immunologic and biological factors | A collective grouping for biologically active substances that play a role in the functioning of the immune system and those that show biological or physiological activity. (12 Dec 1998) |
| immunologic factors | Biologically active substances whose activities affect or play a role in the functioning of the immune system. (12 Dec 1998) |
| initiation factors | The set of catalytic proteins required, in addition to mRNA and ribosomes, for protein synthesis to begin. In bacteria three distinct proteins have been identified: if 1 (8 kD), IF 2 (75 kD) and IF 3 (30 kD). at least 6-8 proteins have been identified in eukaryotes. IFs 1 and 2 enhance the binding of initiator tRNA to the initiation complex. (18 Nov 1997) |
| insulin-like growth factors | Peptides whose formation is stimulated by growth hormone. These peptides bring about peripheral tissue effects of that hormone and have high (about 70%) homology to human insulin. Synonym: somatomedins. (05 Mar 2000) |
| ischemia-modifying factors | Various factors that play a role in determining the extent of necrosis with cerebral stroke; these include blood viscosity and osmolality, the blood pressure, and the anatomy of the neck and intracranial arteries. (05 Mar 2000) |
| oesophageal carcinoma risk factors | <radiology> P Plummer-Vinson Web, A achalasia, alcohol, B Barrett oesophagus, S stricture, T tylosis, tobacco see: oesophageal carcinoma (12 Dec 1998) |
| thyroid carcinoma risk factors | <radiology> Increased risk of malignancy: young female, male, history of radiation to head or neck, hard lesion, other neck masses, no shrinkage on TSH, family hx of thyroid carcinoma see: thyroid carcinoma (12 Dec 1998) |
| time factors | Elements of limited time intervals, contributing to particular results or situations. (12 Dec 1998) |
| transcription factors | Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process. (12 Dec 1998) |